News
-
-
-
-
-
-
-
PRESS RELEASE
APPULSE CORPORATION (Listed on the TSX Venture Exchange - Symbol 'APL') Reporting results for the Nine Months ended September 30, 2025
Appulse Corporation reports financial results for the nine-month period ended September 30, 2025, showing a net loss of ($70,000) and total assets of $4,082,000. Management aims to maximize shareholder value -
PRESS RELEASE
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
Onco-Innovations partners with Dalton Pharma Services for A83B4C63 manufacturing optimization and scale-up activities, aiming for future clinical material production -
-
